未登录

B

Boon Shing Tan

international medical university malaysia

H指数:12

被引数:846

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety profile of sikamat virus and its oncolytic potential in leukemic cells and cancer stem cells

西卡马特病毒的安全性特征及其在白血病细胞和癌症干细胞中的溶瘤潜力

SCIENTIFIC REPORTS

IF3.9

2025-04-220

OA

WD40 protein Wuho controls germline homeostasis via TRIM-NHL tumor suppressor Mei-p26 in Drosophila

IF3.6

2020-01-1511

OA

Histone deacetylase (HDAC) inhibitors and doxorubicin combinations target both breast cancer stem cells and non-stem breast cancer cells simultaneously

组蛋白去乙酰化酶 (HDAC) 抑制剂和阿霉素组合同时靶向乳腺癌干细胞和非干细胞乳腺癌细胞

BREAST CANCER RESEARCH AND TREATMENT

IF3

2019-11-2935

PREAI

LncRNA NORAD is repressed by the YAP pathway and suppresses lung and breast cancer metastasis by sequestering S100P

IF7.3

2019-04-0994

PREAI

BAT8003, a potent anti-Trop-2 antibody-drug conjugate, for the treatment of triple negative breast cancer

CANCER RESEARCH

IF16.6

2019-02-156

PRE

BAT8001, a potent anti-HER2 antibody-drug conjugate with a novel stable linker for the treatment of HER2-positive breast cancer

CANCER RESEARCH

IF16.6

2019-02-153

PRE

Single-walled carbon nanotubes (SWCNTs) inhibit heat shock protein 90 (HSP90) signaling in human lung fibroblasts and keratinocytes

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

2017-08-0113

PREAI

Jerantinine A induces tumor-specific cell death through modulation of splicing factor 3b subunit 1 (SF3B1)

SCIENTIFIC REPORTS

IF3.9

2017-02-1549

OAAI

Metformin synergizes 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) combination therapy through impairing intracellular ATP production and DNA repair in breast cancer stem cells

IF8.1

2015-08-1559

PREAI

Targeting breast cancer stem cells and non-stem breast cancer cells through combination therapies

CANCER RESEARCH

IF16.6

2015-08-010

PRE

Mutant p53-R273H mediates cancer cell survival and anoikis resistance through AKT-dependent suppression of BCL2-modifying factor (BMF)

CELL DEATH & DISEASE

IF9.6

2015-07-1694

OAAI

p53 mutant regulates a network of cellular anoikis through activation of AKT and suppression of BMF

CANCER RESEARCH

IF16.6

2014-10-010

PRE

Metformin synergizes 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) sensitivity in breast cancer stem cells and non-stem breast cancer cells

CANCER RESEARCH

IF16.6

2014-10-010

PRE

6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor γ (PPARγ)

6-紫胶通过激活过氧化物酶体增殖物激活受体 γ (ppar γ) 抑制乳腺癌和结肠癌细胞的增殖

IF10.1

2013-08-0182

PRE

Suppression of BCL-2 synergizes cisplatin sensitivity in nasopharyngeal carcinoma cells

IF10.1

2012-01-0140

PRE

CYP2S1 and CYP2W1 Mediate 2-(3,4-Dimethoxyphenyl)-5-Fluorobenzothiazole (GW-610, NSC 721648) Sensitivity in Breast and Colorectal Cancer Cells

MOLECULAR CANCER THERAPEUTICS

IF5.5

2011-10-0968

OAAI

Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73

BREAST CANCER RESEARCH AND TREATMENT

IF3

2010-08-0552

PREAI